Michael H. Davidson, Chief Executive Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 443,707 shares at $33.25 ($14.8M) on 2026-03-02, disclosed to the SEC on 2026-03-02.
Open-market sale of $14.8M NAMS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NAMS | BUY | 2024-08-22 | $81K | — | Filing → |
| NAMS | BUY | 2024-06-24 | $173K | — | Filing → |
| CLBS | BUY | 2020-09-10 | $100K | — | Filing → |